Cadence Reports Record $8.1 Billion Backlog and Lifts Full-Year Outlook
Cadence beats Q2 expectations with $2.11 EPS and $1.58B revenue.
Markets move fast. You should move faster. Be the first to know when deals break, stocks move, or biotech headlines hit. Sign up to get breaking news alerts the moment they happen.
Cadence beats Q2 expectations with $2.11 EPS and $1.58B revenue.
Samsung locks in a $200 billion multi-year deal with Broadcom for AI chips, HBM memory & foundry through 2030—boosting its race against TSMC.
China begins producing its own immersion DUV lithography machines. A state-backed firm will deliver units to SMIC and other companies in 2026.
Piper Sandler upgrades Rivian to Overweight with a $20 target, citing smooth R2 launch, stronger demand, and a de-risked balance sheet.
Circle buys nearly 1,000 blockchain patents from IBM, becoming the top U.S. holder.
Jefferies upgrades Ford to Buy ($17.50 PT) and GM to Buy ($99 PT). Stronger production, healthy U.S. demand and solid 2027 outlook drive the dual upgrades.